Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

0.3142
+0.02036.91%
Post-market: 0.3031-0.0111-3.53%19:58 EDT
Volume:1.11M
Turnover:332.47K
Market Cap:15.67M
PE:-0.09
High:0.3157
Open:0.2990
Low:0.2800
Close:0.2939
52wk High:1.45
52wk Low:0.1772
Shares:49.88M
Float Shares:30.51M
Volume Ratio:0.11
T/O Rate:3.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5840
EPS(LYR):-3.9532
ROE:--
ROA:-141.53%
PB:-1.02
PE(LYR):-0.08

Loading ...

Company Profile

Company Name:
AEON Biopharma
Exchange:
AMEX
Establishment Date:
- -
Employees:
8
Office Location:
5 Park Plaza,Suite 1750,Irvine,California,United States
Zip Code:
92614
Fax:
- -
Introduction:
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.